SPI
18.392,88
PKT
-158,21
PKT
-0,85
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.07.12 | Clariant hold | ING | |
| 25.07.12 | UBS outperform | Exane-BNP Paribas SA | |
| 25.07.12 | Rieter neutral | Sarasin Research | |
| 25.07.12 | Lonza neutral | Sarasin Research | |
| 25.07.12 | UBS neutral | Nomura | |
| 25.07.12 | Novartis buy | Nomura | |
| 25.07.12 | Swatch (I) buy | UBS AG | |
| 25.07.12 | Roche kaufen | Sarasin Research | |
| 25.07.12 | Ascom buy | UBS AG | |
| 25.07.12 | Novartis kaufen | Sarasin Research | |
| 25.07.12 | Swiss Re buy | Vontobel Research | |
| 25.07.12 | Rieter hold | Vontobel Research | |
| 25.07.12 | Lonza hold | Vontobel Research | |
| 25.07.12 | Comet buy | Vontobel Research | |
| 25.07.12 | Holcim hold | Vontobel Research | |
| 24.07.12 | Swatch (I) buy | Sarasin Research | |
| 24.07.12 | UBS neutral | Sarasin Research | |
| 24.07.12 | UBS hold | Commerzbank Corp. & Markets | |
| 24.07.12 | ams-OSRAM buy | Vontobel Research | |
| 24.07.12 | Julius Bär equal-weight | Morgan Stanley | |
| 24.07.12 | Swiss Re neutral | Nomura | |
| 24.07.12 | Helvetia Baloise reduce | Nomura | |
| 24.07.12 | Swiss Life buy | Nomura | |
| 24.07.12 | ALSO hold | Vontobel Research | |
| 24.07.12 | Sulzer buy | Vontobel Research | |
| 24.07.12 | Swatch (I) buy | Vontobel Research | |
| 23.07.12 | Julius Bär buy | Sarasin Research | |
| 23.07.12 | Julius Bär buy | ING | |
| 23.07.12 | Holcim buy | Société Générale Group S.A. (SG) | |
| 23.07.12 | UBS neutral | UBS AG | |
| 23.07.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 23.07.12 | Arbonia hold | Vontobel Research | |
| 23.07.12 | Novartis hold | Vontobel Research | |
| 23.07.12 | Julius Bär hold | Vontobel Research | |
| 23.07.12 | OC Oerlikon buy | Vontobel Research | |
| 23.07.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 20.07.12 | Sulzer buy | Sarasin Research | |
| 20.07.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 20.07.12 | BB Biotech halten | Independent Research GmbH | |
| 20.07.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) |